Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature

Fig. 4

The distribution of immune-related lncRNAs model score, RFS, and RFS status in the primary cohort (a) and validation cohort (b). The dotted line indicates the optimal cutoff value of the model score to divide patients into the low- and high-risk set. Kaplan–Meier curves of the low- and high-risk patients based on the immune-related lncRNAs model in the primary cohort (c) and validation cohort (d)

Back to article page